Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Knowing what data is needed for financial analysis is crucial for accurate assessments. Gather the essential information to make informed financial decisions.
26,603 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Eos Energy Enterprises missed revenue expectations for Q4 2025, sparking a 39% one-day drop and renewed debate about ...
U.S. M2 hit a fresh high in January 2026, but Bitcoin hasn’t followed the traditional liquidity playbook. Here’s what...
NVIDIA stock rose on speculation it is crafting a Groq-based AI chip to challenge Broadcom and Alphabet's TPU. Cramer...
Pi Network’s token jumped 8.5% in today’s session, rising to a multi-week high as upgrades roll out and unlock schedu...
A new generation of unmanned systems is changing strategy and markets alike. Investors are watching how the rise comb...
Two tech titans sit on sale, but only one may fit a patient investor's plan. This guide breaks down the case for Micr...
Ethereum holds the $2,000 line as RSI dips toward oversold. Traders await a decisive move as volumes ease and liquidi...
Oil prices hover near $91 per barrel on March 11, 2026, with Brent at about $90.96. Analysts say supply discipline an...
Institutional demand is reshaping crypto markets as investors lean on options to define risk on large Bitcoin positio...
Southern Company is near Dividend Aristocrat territory after two decades of increases, yet a massive five-year capita...
In a volatile economy, boards are adjusting performance targets to preserve executive compensation. This piece explai...